Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Kaito

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Bone Marrow Transplantation|February 12, 2020
Allogeneic hematopoietic stem cell transplantation for adult patients with B-cell acute lymphoblastic leukemia harboring t(1;19)(q23;p13.3); comparison with normal karyotypeSatoshi Kaito, Yuho Najima, Kaito Harada, et al.
Blood Advances|March 20, 2020
Heterogeneous impact of cytomegalovirus reactivation on nonrelapse mortality in hematopoietic stem cell transplantationSatoshi Kaito, Yujiro Nakajima, Konan Hara, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 6, 2020
[Tyrosine kinase inhibitor maintenance therapy following allogenic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia]Tomoyuki Uchida, Noriko Doki, Yuya Kishida, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 17, 2017
Retrospective analysis of clinical outcomes of the patients with chronic myeloid leukemia who stopped administration of tyrosine kinase inhibitors: a single institution experienceYasushi Senoo, Kosuke Yoshioka, Satoshi Kaito, et al.
Annals of Hematology|December 2, 2019
Unmanipulated haploidentical hematopoietic stem cell transplantation using very low-dose antithymocyte globulin and methylprednisolone in adults with relapsed/refractory acute leukemiaTatsuya Konishi, Noriko Doki, Akihito Nagata, et al.
Journal of Radiation Research|September 5, 2020
Safety of total body irradiation using intensity-modulated radiation therapy by helical tomotherapy in allogeneic hematopoietic stem cell transplantation: a prospective pilot studyTatsuya Konishi, Hiroaki Ogawa, Yuho Najima, et al.
Pathology Oncology Research : POR|December 23, 2016
Central Nervous System Involvement at the Time of Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with a Poor Outcome in Patients with Acute Myeloid LeukemiaShuntaro Ikegawa, Noriko Doki, Satoshi Kaito, et al.
Bone Marrow Transplantation|May 23, 2024
Azacitidine and gemtuzumab ozogamicin as post-transplant maintenance therapy for high-risk hematologic malignanciesSatoshi Kaito, Yuho Najima, Daichi Sadato, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 13, 2016
[Chronic myelogenous leukemia initially presenting with multiple subcutaneous tumors due to extramedullary hematopoiesis]Shuhei Kurosawa, Noriko Doki, Satoshi Kaito, et al.
International Journal of Hematology|August 28, 2016
Comparison of transplant outcomes and economic costs between biosimilar and originator filgrastim in allogeneic hematopoietic stem cell transplantationKaito Harada, Yuta Yamada, Tatsuya Konishi, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Bone Marrow Transplantation|February 12, 2020
Allogeneic hematopoietic stem cell transplantation for adult patients with B-cell acute lymphoblastic leukemia harboring t(1;19)(q23;p13.3); comparison with normal karyotypeSatoshi Kaito, Yuho Najima, Kaito Harada, et al.
Blood Advances|March 20, 2020
Heterogeneous impact of cytomegalovirus reactivation on nonrelapse mortality in hematopoietic stem cell transplantationSatoshi Kaito, Yujiro Nakajima, Konan Hara, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 6, 2020
[Tyrosine kinase inhibitor maintenance therapy following allogenic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia]Tomoyuki Uchida, Noriko Doki, Yuya Kishida, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 17, 2017
Retrospective analysis of clinical outcomes of the patients with chronic myeloid leukemia who stopped administration of tyrosine kinase inhibitors: a single institution experienceYasushi Senoo, Kosuke Yoshioka, Satoshi Kaito, et al.
Annals of Hematology|December 2, 2019
Unmanipulated haploidentical hematopoietic stem cell transplantation using very low-dose antithymocyte globulin and methylprednisolone in adults with relapsed/refractory acute leukemiaTatsuya Konishi, Noriko Doki, Akihito Nagata, et al.
Journal of Radiation Research|September 5, 2020
Safety of total body irradiation using intensity-modulated radiation therapy by helical tomotherapy in allogeneic hematopoietic stem cell transplantation: a prospective pilot studyTatsuya Konishi, Hiroaki Ogawa, Yuho Najima, et al.
Pathology Oncology Research : POR|December 23, 2016
Central Nervous System Involvement at the Time of Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with a Poor Outcome in Patients with Acute Myeloid LeukemiaShuntaro Ikegawa, Noriko Doki, Satoshi Kaito, et al.
Bone Marrow Transplantation|May 23, 2024
Azacitidine and gemtuzumab ozogamicin as post-transplant maintenance therapy for high-risk hematologic malignanciesSatoshi Kaito, Yuho Najima, Daichi Sadato, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 13, 2016
[Chronic myelogenous leukemia initially presenting with multiple subcutaneous tumors due to extramedullary hematopoiesis]Shuhei Kurosawa, Noriko Doki, Satoshi Kaito, et al.
International Journal of Hematology|August 28, 2016
Comparison of transplant outcomes and economic costs between biosimilar and originator filgrastim in allogeneic hematopoietic stem cell transplantationKaito Harada, Yuta Yamada, Tatsuya Konishi, et al.
Pageof 5